169 related articles for article (PubMed ID: 16714389)
1. Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice.
Bhuller Y; Jeng W; Wells PG
Toxicol Sci; 2006 Sep; 93(1):146-55. PubMed ID: 16714389
[TBL] [Abstract][Full Text] [Related]
2. A developmental role for ataxia-telangiectasia mutated in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture.
Bhuller Y; Wells PG
Toxicol Sci; 2006 Sep; 93(1):156-63. PubMed ID: 16790486
[TBL] [Abstract][Full Text] [Related]
3. Embryoprotective role of endogenous catalase in acatalasemic and human catalase-expressing mouse embryos exposed in culture to developmental and phenytoin-enhanced oxidative stress.
Abramov JP; Wells PG
Toxicol Sci; 2011 Apr; 120(2):428-38. PubMed ID: 21252394
[TBL] [Abstract][Full Text] [Related]
4. Effect of the reduction of superoxide dismutase 1 and 2 or treatment with alpha-tocopherol on tumorigenesis in Atm-deficient mice.
Erker L; Schubert R; Elchuri S; Huang TT; Tarin D; Mueller K; Zielen S; Epstein CJ; Wynshaw-Boris A
Free Radic Biol Med; 2006 Aug; 41(4):590-600. PubMed ID: 16863992
[TBL] [Abstract][Full Text] [Related]
5. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
[TBL] [Abstract][Full Text] [Related]
6. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M
Breast Cancer Res; 2005; 7(1):R164-70. PubMed ID: 15642165
[TBL] [Abstract][Full Text] [Related]
7. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity.
Yoshida M; Shiojima I; Ikeda H; Komuro I
J Mol Cell Cardiol; 2009 Nov; 47(5):698-705. PubMed ID: 19660469
[TBL] [Abstract][Full Text] [Related]
8. Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor.
Erker L; Schubert R; Yakushiji H; Barlow C; Larson D; Mitchell JB; Wynshaw-Boris A
Hum Mol Genet; 2005 Jun; 14(12):1699-708. PubMed ID: 15888486
[TBL] [Abstract][Full Text] [Related]
9. Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice.
Abramov JP; Wells PG
FASEB J; 2011 Jul; 25(7):2188-200. PubMed ID: 21478259
[TBL] [Abstract][Full Text] [Related]
10. Ataxia telangiectasia mutated (Atm) knockout mice as a model of osteopenia due to impaired bone formation.
Hishiya A; Ito M; Aburatani H; Motoyama N; Ikeda K; Watanabe K
Bone; 2005 Oct; 37(4):497-503. PubMed ID: 16027059
[TBL] [Abstract][Full Text] [Related]
11. Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.
Bowen TJ; Yakushiji H; Montagna C; Jain S; Ried T; Wynshaw-Boris A
Cancer Res; 2005 Oct; 65(19):8736-46. PubMed ID: 16204043
[TBL] [Abstract][Full Text] [Related]
12. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
Winn LM; Wells PG
Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765
[TBL] [Abstract][Full Text] [Related]
13. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling.
Kim J; Wong PK
Stem Cells; 2009 Aug; 27(8):1987-98. PubMed ID: 19544430
[TBL] [Abstract][Full Text] [Related]
14. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice.
Reliene R; Fischer E; Schiestl RH
Cancer Res; 2004 Aug; 64(15):5148-53. PubMed ID: 15289318
[TBL] [Abstract][Full Text] [Related]
15. ATM is required for the cellular response to thymidine induced replication fork stress.
Bolderson E; Scorah J; Helleday T; Smythe C; Meuth M
Hum Mol Genet; 2004 Dec; 13(23):2937-45. PubMed ID: 15459181
[TBL] [Abstract][Full Text] [Related]
16. Resistance of CD-1 and ogg1 DNA repair-deficient mice to thalidomide and hydrolysis product embryopathies in embryo culture.
Lee CJ; Gonçalves LL; Wells PG
Toxicol Sci; 2011 Jul; 122(1):146-56. PubMed ID: 21505090
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice.
Reliene R; Schiestl RH
DNA Repair (Amst); 2006 Jul; 5(7):852-9. PubMed ID: 16781197
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and functional characterization of zebrafish ATM.
Imamura S; Kishi S
Int J Biochem Cell Biol; 2005 May; 37(5):1105-16. PubMed ID: 15743681
[TBL] [Abstract][Full Text] [Related]
19. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin.
Kim PM; Winn LM; Parman T; Wells PG
J Pharmacol Exp Ther; 1997 Jan; 280(1):200-9. PubMed ID: 8996197
[TBL] [Abstract][Full Text] [Related]
20. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
Liu L; Wells PG
Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]